Scilex Holding (SCLX) Assets Growth (1y) (2021 - 2026)
Scilex Holding (SCLX) Assets Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 271.80% |
| Dec 31, 2025 | 292.65% |
| Sep 30, 2025 | 174.70% |
| Jun 30, 2025 | -19.89% |
| Mar 31, 2025 | -13.44% |
| Dec 31, 2024 | -8.25% |
| Sep 30, 2024 | 24.71% |
| Jun 30, 2024 | -17.33% |
| Mar 31, 2024 | 6.03% |
| Dec 31, 2023 | 17.08% |
| Sep 30, 2023 | -20.63% |
| Jun 30, 2023 | -11.13% |
| Mar 31, 2023 | -38.96% |
| Dec 31, 2022 | 11.03% |
| Sep 30, 2022 | -27.34% |
| Jun 30, 2022 | 1.72% |
| Mar 31, 2022 | 0.65% |
| Dec 31, 2021 | 38,966.79% |